Batya Swift Yasgur, MA, LSW Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD). Several studies […]

Tim Newman Glutamate is an amino acid and the primary excitatory neurotransmitter in the brain. In recent years, studies have hinted that glutamate might be involved in anxiety. Reductions in glutamate activity seem to increase anxious behavior, and glutamate levels within the hippocampus — […]